ArticleFrontiers in artificial intelligence2025
Triboostcardio ensemble model for cardiovascular disease detection using advanced blockchain-enabled health monitoring.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Heart diseases (CVDs) are a major cause of morbidity and mortality in all global regions and thus there is the pressing need to develop early detection and effective management approaches. Traditional cardiovascular monitoring systems do not necessarily have real-time analyzing solutions and individual understanding, which leads to delayed interventions. Moreover, one of the greatest issues in digital healthcare applications remains to be data privacy and security. Methods: The proposed research is to present a developed model of CVD detection that will combine Internet of Things (IoT)-based wearable devices, electronic clinical records, and access control using blockchain. The system starts by registering patients and medical personnel and then proceeds with collecting physiological as well as clinical data. Kalman filtering helps in improving data reliability in the pre-processing stage. Shallow and deep feature extraction methods are used to describe complicated patterns of data. A Refracted Sand Cat Swarm Optimization (SCSO) algorithm is used as part of feature maximization. A new TriBoostCardio Ensemble model (CatBoost, AdaBoost, and LogitBoost) is used to conduct the classification task and enhance the predictive accuracy. Smart contracts provide safe and transparent access to health information. Results: There are experimental results that the proposed framework enhances high predictive accuracy and detecting cardiovascular diseases earlier than traditional ones. The combination between SCSO feature selection and the TriBoostCardio Ensemble model improves the sturdiness of the model and precision of classification. Discussion: Besides the fact that the presented framework promotes the accuracy and timeliness of CVD detection, it also way to deal with important problems related to the data privacy and integrity with the help of blockchain-based access control. This solution offers a stable and trustworthy solution to the current healthcare systems with the combination of the smart optimization of features, ensemble learning, and secure data management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.